Your fact-checks will appear here
The use of pharmacovigilance systems to detect rare but biologically informative oncologic events.
There is no authoritative, product-specific safety dossier for Memoblast in the reporting provided, so definitive lists of its risks and side effects cannot be drawn from these sources; the only Memob...
Cancer registries and operate on different strengths: registries provide high-quality, population‑level, long‑term incidence and survival data, while vaccine surveillance systems collect near‑real‑tim...
commonly causes mild, transient symptoms such as itching, headache, dizziness, nausea, diarrhea and fatigue, while more serious reactions—especially neurologic events and severe allergic responses—hav...
Off‑label and veterinary use of during the COVID‑19 pandemic produced a measurable uptick in reported adverse events and produced clearer “signals,” driven largely by misuse, overdosing and ingestion ...
No publicly available sources in the provided reporting name or describe “garaherb” specifically, so direct, product-level adverse-event counts for garaherb cannot be reported from these documents; in...
Human and veterinary drugs are regulated under broadly similar quality and GMP frameworks, but important practical and technical differences govern testing, approval dossiers, food‑safety requirements...
Regulators do more than rubber‑stamp sponsor analyses: they critically review, challenge, and sometimes re‑analyse datasets and models submitted for new drug approvals, and they continue to scrutinize...
Existing clinical evidence that ivermectin causes liver enzyme elevations in humans is limited but real: randomized/tolerability trials and pharmacovigilance databases document transient aminotransfer...
The materials provided do not contain independent clinical trials or standalone adverse-event reports for a product named "Karylief"; instead, reporting focuses on Karyopharm’s clinical programs for c...
Real‑world pharmacovigilance and observational studies consistently identify gastrointestinal events—nausea, vomiting, diarrhea, constipation and dyspepsia—as the most common adverse events (AEs) with...